Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Formoterol fumarate dihydrate
Chiesi Ltd
R03AC13
Formoterol fumarate dihydrate
12microgram/1dose
Pressurised inhalation
Inhalation
No Controlled Drug Status
Valid as a prescribable product
BNF: 03010101; GTIN: 5028613002759
87H03.08/01 Note per il fornitore: Microforatura lungo la piega centrale a discrezione del fornitore / PIEGA CON CODICI A BARRE A VISTA PAG. 1/2 PACKAGE LEAFLET: INFORMATION FOR THE USER ATIMOS ® MODULITE ® 12 MICROGRAMS/ACTUATION PRESSURISED INHALATION SOLUTION Formoterol fumarate dihydrate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them even if their symptoms are the same as yours. - I f any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. WHAT ATIMOS MODULITE IS AND WHAT IT IS USED FOR 2. BEFORE YOU USE ATIMOS MODULITE 3. HOW TO USE ATIMOS MODULITE 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE ATIMOS MODULITE 6. FURTHER INFORMATION 1. WHAT ATIMOS MODULITE IS AND WHAT IT IS USED FOR Atimos Modulite is an inhalation medicine delivering its active ingredient directly into your lungs where it is needed. It is used to treat the symptoms of wheezing and breathlessness in patients with moderate to severe asthma. Its active ingredient, formoterol fumarate, belongs to a group of medicines called bronchodilators: they make breathing easier by relaxing muscle spasms in the air passages of the lungs. Regular use of Atimos Modulite together with steroids (either by inhaler or by mouth), will help to prevent breathing problems over the long term. Atimos Modulite can also be used for the relief of symptoms such as cough, wheezing and shortness of breath in patients with chronic obstructive pulmonary disease (COPD) who require long-term regular bronchodilator therapy. 2. BEFORE YOU USE ATIMOS MODULITE DO NOT USE ATIMOS MODULITE: • if you are allergic to formoterol or to any of the ingredients of Atimos Modulite. • TO TREAT A SUDDEN ATTACK OF BREATHLESSNESS. It will not help. Use a relie Read the complete document
OBJECT 1 ATIMOS MODULITE 12 MICROGRAMS INHALER Summary of Product Characteristics Updated 21-Oct-2015 | Chiesi Limited 1. Name of the medicinal product Atimos Modulite 12 micrograms/actuation pressurised inhalation solution 2. Qualitative and quantitative composition Each metered dose contains 12 micrograms of formoterol fumarate dihydrate. This corresponds to a delivered dose of 10.1 micrograms. For a full list of excipients, see section 6.1 3. Pharmaceutical form Pressurised inhalation solution 4. Clinical particulars 4.1 Therapeutic indications For the long-term symptomatic treatment of persistent, moderate to severe asthma in patients requiring regular bronchodilator therapy in combination with long-term anti-inflammatory therapy (inhaled and / or oral glucocorticoids). Glucocorticoid therapy should be continued on a regular basis. Atimos is indicated for the relief of broncho-obstructive symptoms in patients with chronic obstructive pulmonary disease (COPD). 4.2 Posology and method of administration The dosage depends on the type and severity of disease. The following dosages are recommended for adults, including elderly patients, and adolescents aged 12 years and above: Asthma Adults and adolescents aged 12 years and above Usually one actuation in the morning and evening (24 micrograms of formoterol fumarate dihydrate per day). In severe cases, up to a maximum of two actuations in the morning and evening (48 micrograms of formoterol fumarate dihydrate per day). The maximum daily dose is 4 actuations (48 micrograms of formoterol fumarate dihydrate). Children younger than 12 years of age: The safety and efficacy of Atimos Modulite in children younger than 12 years of age has not been established yet, therefore Atimos Modulite should not be used in children. Chronic Obstructive Pulmonary Disease (COPD) Adults (aged 18 years and above) The usual dose is one actuation twice daily (one in the morning and one in the evening, 24 micrograms formoterol fumarate dihydrate per day). The daily dose for regular use shoul Read the complete document